Laddar...
Electroencephalographic Power Spectral Density Profile of the Orexin Receptor Antagonist Suvorexant in Patients with Primary Insomnia and Healthy Subjects
STUDY OBJECTIVES: Suvorexant, an orexin receptor antagonist, improves sleep in healthy subjects (HS) and patients with insomnia. We compared the electroencephalographic (EEG) power spectral density (PSD) profile of suvorexant with placebo using data from a phase 2 trial in patients with insomnia. We...
Sparad:
| Huvudupphovsmän: | , , , , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Associated Professional Sleep Societies, LLC
2014
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4173918/ https://ncbi.nlm.nih.gov/pubmed/25197807 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5665/sleep.4068 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|